TScan Therapeutics, Inc. (TCRX) vs Jin Medical International Ltd. (ZJYL)
A side-by-side comparison of TScan Therapeutics, Inc. and Jin Medical International Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
TCRX
TScan Therapeutics, Inc.
$0.28HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ZJYL
Jin Medical International Ltd.
$1.99HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — TCRX vs ZJYL
growth of $100 · dividends reinvested · last 4yTCRX -87.7% (-40.8%/yr)ZJYL -75.1% (-29.4%/yr)ZJYL compounded faster over this window
TCRX ZJYL
TCRX vs ZJYL: by the numbers
- •TCRX is the larger company ($17M vs $16M market cap).
- •ZJYL is profitable (5.76% net margin) while TCRX runs a net loss (-1655.35%).
- •ZJYL grew revenue faster over the past five years (5.02% vs 3.60% CAGR).
Metrics side by side
Valuation
| Metric | TCRX | ZJYL |
|---|---|---|
| P/S ratio | 2.37 | N/A |
| P/B ratio | 0.24 | 0.51 |
Profitability
| Metric | TCRX | ZJYL |
|---|---|---|
| Gross margin | 72.24% | 29.22% |
| Operating margin | -1315.38% | 2.94% |
| Net margin | -1655.35% | 5.76% |
| ROE | -170.55% | 4.02% |
| ROIC | -79.20% | 1.09% |
Growth (annualized)
| Metric | TCRX | ZJYL |
|---|---|---|
| Revenue CAGR (5Y) | 3.60% | 5.02% |
| EPS CAGR (5Y) | N/A | 6.40% |
| Total return CAGR (5Y) | -48.85% | N/A |
Frequently asked
- Which has grown faster, TCRX or ZJYL?
- Over the past five years, ZJYL grew revenue faster — TCRX at a 3.60% CAGR versus ZJYL at 5.02%.
- Is TCRX or ZJYL more profitable?
- ZJYL runs the higher net margin — TCRX at -1655.35% versus ZJYL at 5.76%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.